L-Y-METHYLENEGLUTAMINE COMPOUNDS AND METHODS OF USE
Disclosed are substantially pure L-y-methyleneglutamine, L-y-methyleneglutamic acid, and/or amide derivatives, and methods of use thereof. In particular, the presently disclosed subject matter relates to L-y-methyleneglutamine, L-y-methyleneglutamic acid, and/or amide derivatives thereof, and method...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English |
Published |
25.08.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Disclosed are substantially pure L-y-methyleneglutamine, L-y-methyleneglutamic acid, and/or amide derivatives, and methods of use thereof. In particular, the presently disclosed subject matter relates to L-y-methyleneglutamine, L-y-methyleneglutamic acid, and/or amide derivatives thereof, and methods of treating cancer. The method comprises administering one or more substantially pure L-y-methyleneglutamine, L-y-methyleneglutamic acid, and/or amide derivatives to a subject in need thereof. |
---|---|
Bibliography: | Application Number: US202017597550 |